Pulmonary atypical carcinoid: Predictors of survival in 106 cases
about
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumoursPulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsNeuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas.Survival and Predictors of Death for Patients with Bronchopulmonary Carcinoid at a Danish Tertiary NET Centre.Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis.Bronchoscopic long-term palliation of a recurrent atypical carcinoid tumor.Large cell neuroendocrine carcinoma of the larynx: definition of an entityAdvances in neuroendocrine lung tumors.Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.Huge hilar carcinoid tumor resected by transsternal pneumonectomy: a case presentationLong-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis.Typical bronchial carcinoid metastasizing to the brain: a case presentation.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 scoreNeuroendocrine tumour management: a team approach.Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.Cardiothoracic manifestations of neuroendocrine tumours.Pure bronchoplastic resections of the bronchus without pulmonary resection for endobronchial carcinoid tumours.Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential.Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumorsUnraveling tumor grading and genomic landscape in lung neuroendocrine tumors.Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.Distinctive pathological and clinical features of lung carcinoids with high proliferation index.SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).Using electron microscopy and multivariate cluster analysis to determine diagnosis and prognosis in cases of neuroendocrine lung carcinoma.Delayed recurrence of atypical pulmonary carcinoid cluster: a rare occurrence.Ki-67 expression in pulmonary tumors.Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.[Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid].Pulmonary neuroendocrine tumors: an entity in search of cytologic criteria.Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.An exploration of pathways involved in lung carcinoid progression using gene expression profiling.Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue.p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors.
P2860
Q24685837-8A4460B4-6F9A-47FB-AEBF-5D4BA3CA178CQ26996521-588FBC03-81A9-4EF3-ABB7-E3FE941B0BCFQ30309036-EF1003AA-3143-4F59-BF10-1B812AA1066EQ33770786-722738D0-4E4F-4C47-A248-279DF75EF784Q33789403-FD19D933-197B-485D-A9F6-921944F6B31FQ33803632-D9EC96D1-5F78-47DB-9095-F47F58C19D6BQ34072071-83EE5FB3-7396-4EB9-9AEF-F3A160E87C1FQ34143347-80F3DC4D-DED7-4868-8E7F-330892A61F1DQ34363206-8A367904-C47C-43E5-94C3-19F2D9E29DFCQ35167949-493764AE-4D43-4061-ACB8-3E0F66C4769CQ35275740-AAD3D4DE-C1D1-48B1-8750-7D8791D3F041Q35667613-B2109D53-ED41-4735-AAE4-E29AC1446318Q35710713-E6AACA34-7B2A-4C04-A47C-86F184A87CB3Q35760798-F5FF1339-D1F0-4F49-98CD-4EC2468C64E0Q35972107-18EDE3B8-E48B-4B75-A5A8-1646A6DDBCFFQ36027156-3B46E4D3-3DB2-4398-93E6-27C4079E0572Q36413013-83A5EF6C-F38C-48BB-AC2D-14798699C696Q36432090-A9BF7A91-45FA-489F-912D-0FE395E01137Q36839240-CBA2350C-E2C2-4DA2-9EDD-89D658F92DD0Q37024142-140A98F8-4300-4C4E-BBD0-C6F7BE3DC274Q37241681-A5919294-B689-4387-B810-D6138FDB61C4Q37514029-0F111A12-6695-46AE-BE20-9C5FFCCA0F30Q38207553-E830B9E0-01EA-4D2B-BB90-8F5F70D2098FQ38651086-4416CD68-5971-4371-BDF7-A45A72FA2C70Q38718054-E1D13013-CEB6-4642-A195-F5EFEEFB2C48Q39025929-09283AB7-BEB3-48FE-BCCE-E8673C01F43AQ39862466-4CC734B2-4CAE-4577-8F1C-739CD2C1A87AQ41855568-320F7D82-BED4-4E8F-8B4F-5CF6998D22E1Q42372534-CF5AE4FB-BECB-4A06-9A21-4DE3499ABC92Q43275679-356A54F0-20AD-41E9-9112-44B234C369B9Q44553340-3F0911B9-A8F5-4B06-8E4A-87555E4EC0B7Q45816392-A24C47F7-33BB-4D36-BF30-DD0621B1D6E1Q46606606-814EED71-6C04-41C1-92E4-85CBF498A2E8Q47378726-AEE71439-8083-49AB-8F16-00C65512DBD3Q47795731-9C5C283B-E9C0-499E-B712-F50107CD4D6CQ50728982-91314BD2-6A90-4DFC-875C-D78363E56CAAQ51167759-EE8BDD59-BCD2-4FE6-9CBF-1B9DC83767D5Q53502502-A0887689-BD53-49C5-868E-F5DA19B40DFBQ53537207-2748FBCD-403A-4567-8C1D-C42CD98411B9Q54295055-8F89AF51-45D2-4D57-81B3-0F359FEF42CD
P2860
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2000
@uk
name
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@en
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@nl
type
label
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@en
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@nl
prefLabel
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@en
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@nl
P356
P1433
P1476
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
@en
P2093
P304
P356
10.1053/HUPA.2000.19294
P407
P577
2000-10-01T00:00:00Z